Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Vyrix Pharmaceuticals

2013 FOUNDED
M&A STATUS
Merger of Eq. LATEST DEAL TYPE
2 FINANCING ROUNDS
Description

Developer of pharmaceutical products. The company engages in developing and commercializing late-stage prescription pharmaceuticals. It develops Zertaneā„¢, an oral drug in late stage development as a proprietary treatment for premature ejaculation. It is also developing a combination product with Zertane and an erectile dysfunction product to address co-morbid PE and erectile dysfunction.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Acquirer
Primary Office
  • 5445 DTC Parkway
  • Suite 925
  • Greenwood Village, CO 80111
  • United States

Vyrix Pharmaceuticals Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Vyrix Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook

Vyrix Pharmaceuticals Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Vyrix Pharmaceuticals‘s full profile, request access.

Request full access to PitchBook